Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dale Yoo

Clinical Cardiac Electrophysiology McKinney, TX Medical Doctor

NPI 1780799015 CMS profile 262359

7300 Eldorado Pkwy Ste 230, Ste 108, McKinney, TX 75070

Open in the dashboard

General payments

$584,827

1,634 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$120,159 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Dale Yoo of McKinney, TX is reported in the CMS Open Payments database as having received $584,827 across 1,634 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $120,159 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $66,027 231
2024 General $76,904 242
2023 General $87,436 224
2022 General $114,447 236
2021 General $58,335 207
2020 General $61,619 187
2019 General $120,059 307

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dale Yoo
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Dale Yoo were reported at $66,027. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Dale Yoo Clinical Cardiac Electrophysiology median Middle half National median
2019 $120,059 $2,361 $585–$8,260 $163
2020 $61,619 $993 $247–$4,351 $114
2021 $58,335 $1,185 $326–$4,739 $132
2022 $114,447 $2,073 $554–$6,789 $149
2023 $87,436 $2,568 $759–$8,159 $160
2024 $76,904 $2,557 $703–$7,403 $164
2025 $66,027 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $374,796 864 payments
  2. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $118,683 190 payments
  3. Itamar Medical Inc $20,930 9 payments
  4. Sanofi-Aventis U.S. LLC $13,775 38 payments
  5. Pfizer Inc. $9,965 79 payments
  6. Atricure, Inc. $9,927 69 payments
  7. Aziyo Biologics, Inc. $8,390 53 payments
  8. Merck Sharp & Dohme Corporation $5,117 42 payments
  9. Philips Electronics North America Corporation $4,715 14 payments
  10. Medtronic Vascular, Inc. $3,119 35 payments
  11. Other $15,407 241 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $221,635 83 payments
  2. Travel and Lodging $166,620 238 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $118,034 88 payments
  4. Food and Beverage $69,094 1,215 payments
  5. Honoraria $5,000 3 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,200 3 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $1,200 2 payments
  8. Education $44 2 payments
Products named General payments · program years 2019–2025
  1. LifeVest $118,683 190 payments
  2. ENSITE Electrophysiology $40,646 58 payments
  3. ADVISOR $40,565 18 payments
  4. AMPLATZER AMULET $40,543 184 payments
  5. AVEIR $36,415 38 payments
  6. Assurity Pacemaker $35,140 17 payments
  7. ACCENT $18,475 5 payments
  8. WatchPATONE $15,987 6 payments
  9. ENSITE Structural Heart $15,650 41 payments
  10. ENSITE PRECISION $14,626 52 payments
  11. Other $201,560 1,084 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 37 drugs

Part D claims

2,153

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$875,962

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

32.9%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Vyndamax Tafamidis Brand 20 $448,854
Eliquis Apixaban Brand 141 $161,012
Entresto Sacubitril/Valsartan Brand 108 $131,613
Xarelto Rivaroxaban Brand 19 $21,738
Multaq Dronedarone Hcl Brand 18 $19,693
Verquvo Vericiguat Brand 20 $18,342
Farxiga Dapagliflozin Propanediol Brand 19 $16,653
Jardiance Empagliflozin Brand 14 $12,573
Propafenone Hcl Er Propafenone Hcl Brand 31 $8,078
Flecainide Acetate Generic 169 $7,240

The 10 drugs with the highest cost, of 37 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 126 billing codes

Paid by Medicare

$446,915

Of which drugs: $141,860

Medicare patients

378

Average age 76

Services billed

10,027

190 women, 188 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 65%
Arthritis 49%
Heart failure 48%
Ischemic heart disease 42%
Chronic kidney disease 39%
Diabetes 32%
Depression 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VERQUVO
$4,453 20 —
Arcalyst
$91 — —
VYNDAQEL
$70 — —
FUROSCIX
$44 — —
MULTAQ
$33 18 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

1,634 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record